Your browser doesn't support javascript.
loading
HLA-A*33:03-Restricted Activation of Ticlopidine-Specific T-Cells from Human Donors.
Usui, Toru; Tailor, Arun; Faulkner, Lee; Meng, Xiaoli; Farrell, John; Daly, Ann K; Dear, Gordon J; Park, B Kevin; Naisbitt, Dean J.
Afiliação
  • Usui T; MRC Center for Drug Safety Science, Department of Molecular and Clinical Pharmacology , University of Liverpool , Sherrington Building, Ashton Street , Liverpool , L69 3GE , England.
  • Tailor A; MRC Center for Drug Safety Science, Department of Molecular and Clinical Pharmacology , University of Liverpool , Sherrington Building, Ashton Street , Liverpool , L69 3GE , England.
  • Faulkner L; MRC Center for Drug Safety Science, Department of Molecular and Clinical Pharmacology , University of Liverpool , Sherrington Building, Ashton Street , Liverpool , L69 3GE , England.
  • Meng X; MRC Center for Drug Safety Science, Department of Molecular and Clinical Pharmacology , University of Liverpool , Sherrington Building, Ashton Street , Liverpool , L69 3GE , England.
  • Farrell J; MRC Center for Drug Safety Science, Department of Molecular and Clinical Pharmacology , University of Liverpool , Sherrington Building, Ashton Street , Liverpool , L69 3GE , England.
  • Daly AK; Institute of Cellular Medicine, Medical School , Newcastle University , Newcastle NE2 4HH , United Kingdom.
  • Dear GJ; GlaxoSmithKline , Park Road , Ware , Hertfordshire SG12 7BB , United Kingdom.
  • Park BK; MRC Center for Drug Safety Science, Department of Molecular and Clinical Pharmacology , University of Liverpool , Sherrington Building, Ashton Street , Liverpool , L69 3GE , England.
  • Naisbitt DJ; MRC Center for Drug Safety Science, Department of Molecular and Clinical Pharmacology , University of Liverpool , Sherrington Building, Ashton Street , Liverpool , L69 3GE , England.
Chem Res Toxicol ; 31(10): 1022-1024, 2018 10 15.
Article em En | MEDLINE | ID: mdl-30179004
ABSTRACT
The HLA class I allele HLA-A*3303 is a risk factor for ticlopidine-induced liver injury. Herein, we show HLA class I-restricted ticlopidine-specific CD8+ T-cell activation in healthy donors expressing HLA-A*3303. Cloned CD8+ T-cells proliferated and secreted IFN-γ in the presence of ticlopidine and autologous antigen presenting cells. A reduction of the T-cell response after blocking with HLA-class I and HLA-A*33 antibodies indicates that the interaction between drugs and the HLA allele detected in genetic association studies may be important for T-cell activation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ticlopidina / Ativação Linfocitária / Antígenos HLA-A / Linfócitos T CD8-Positivos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ticlopidina / Ativação Linfocitária / Antígenos HLA-A / Linfócitos T CD8-Positivos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article